T1	Participants 69 96	premenopausal breast cancer
T2	Participants 699 737	premenopausal women with breast cancer
T3	Participants 859 940	500 available tumour specimens from 564 premenopausal patients with breast cancer
T4	Participants 1863 1890	patients with breast cancer
